These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 15943890)
1. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer. Belani CP Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890 [No Abstract] [Full Text] [Related]
2. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA; Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766 [TBL] [Abstract][Full Text] [Related]
3. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer. Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183 [TBL] [Abstract][Full Text] [Related]
4. Lung cancer adjuvant therapy. Horn L; Sandler A Cancer J; 2007; 13(3):210-6. PubMed ID: 17620772 [TBL] [Abstract][Full Text] [Related]
5. Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung. Carruthers R; O'Rourke N; Mohammed N; Hicks J; Brisbane I Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):561-2. PubMed ID: 21676603 [No Abstract] [Full Text] [Related]
6. Perioperative therapy of non-small cell lung cancer: a review of adjuvant and neoadjuvant approaches. Friedland DM; Comis RL Semin Oncol; 1995 Dec; 22(6):571-81. PubMed ID: 8539633 [No Abstract] [Full Text] [Related]
8. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154 [TBL] [Abstract][Full Text] [Related]
9. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491 [TBL] [Abstract][Full Text] [Related]
10. Early-stage lung cancer findings end a debate, put focus on next steps. McNeil C J Natl Cancer Inst; 2004 Jul; 96(14):1054-5. PubMed ID: 15265961 [No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy for lung cancer. Sauter C N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088320 [No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy for lung cancer. Ikhlaque N; Baumann MA N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703 [No Abstract] [Full Text] [Related]